Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Small Cell Lung Carcinoma × Chloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Neoplasms 1 Gliosarcoma 1

Interventions

Cisplatin 19 Etoposide 17 Carboplatin 16 Topotecan 12 durvalumab 10 Irinotecan 9 pembrolizumab 8 Paclitaxel 7 Nivolumab 7 tremelimumab 6 atezolizumab 6 Radiotherapy 6 Gemcitabine 6 Docetaxel 6 rovalpituzumab tesirine 4 budigalimab 4 Specimen Handling 4 Pemetrexed 4 Ipilimumab 4 Doxorubicin 4 Cyclophosphamide 4 Bortezomib 4 venetoclax 3 talazoparib 3 olaparib 3 Platinum 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Injections 3 Fluorouracil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01575782 2017-07-18

Chloroquine

Maastricht Radiation Oncology

Phase 1 Terminated

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡